AKT1 and invasive breast carcinoma: Increased expression of EZH2 associates with decreased nuclear expression of phospho-BRCA1 (Ser1423) and upregulation of phospho-Akt-1 (Ser473) in ~ 40% of invasive breast carcinomas.